Displaying 611-620 of 803 results for

The world has changed remarkably in 2020. The new decade began with a sense of optimism and historically strong economies in both the commercial aerospace and defense sectors.

Since its first volume, in 2006, this publication has followed the story of the F-35 Joint Strike Fighter, which, through trial and sometimes painful error, has gone from a daring design to a distributed manufacturing supply chain to, finally, a warplane in service around the globe.

The warning about the vulnerability of the aerospace and defense industry’s supply chain came buried in the pages of a report issued by the consulting firm EY two years before the COVID-19 outbreak became a full-blown global crisis.

Before the coronavirus pandemic upended normal life and essentially shut down commercial airliners, the aviation industry had a projected need for 40,000 new aircraft—planes, helicopters, air taxis, and unmanned aerial vehicles—in the next 20 years.

Deloitte and Wichita State University announced the launch of The Smart Factory @ Wichita,

It has become far too rare for manufacturers’ visions of an IIoT-fueled utopia to survive contact with reality. A Cisco survey finds that nearly 75 percent of Industrial Internet of Things (IIoT) projects are failing.

If you were to rebuild your manufacturing business today, would you build it in the same way, or would you shape it differently to address new challenges and future innovations?

Improvements in manufacturing management software, robotics, additive manufacturing and thermal controls are making small batch sizes more cost effective—even for smaller shops. Manufacturing plants are able to reduce inventory, improve throughput and reduce demands on human operators.

We no longer need to accept that it takes a decade to create and make a safe and effective vaccine—thanks in part to smart manufacturing.

In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.